Thursday, November 12, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

NSUN5 Drives Liver Cancer via m5C-EFNA3 Glycolysis

August 3, 2025
in Cancer
Nathaniel Bowman
By Nathaniel Bowman Scienmag Editorial Profile - Precision Oncology
Reading Time: 4 mins read
0
NSUN5 Drives Liver Cancer via m5C-EFNA3 Glycolysis
66
SHARES
602
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking study published in BMC Cancer, researchers have unveiled a novel molecular mechanism that accelerates the progression of liver hepatocellular carcinoma (LIHC), the most common form of liver cancer. This mechanism centers around NSUN5, an RNA methyltransferase enzyme, which promotes tumor growth by modulating glycolysis through m5C methylation of EFNA3, a critical gene involved in the disease. This discovery offers a promising new target for therapeutic intervention, potentially revolutionizing the treatment landscape of LIHC.

Liver hepatocellular carcinoma is notorious for its aggressive nature and poor prognosis, primarily due to late diagnosis and limited effective treatment options. One of the hallmarks of aggressive cancers like LIHC is aerobic glycolysis—often referred to as the Warburg effect—where cancer cells preferentially generate energy through glycolysis even in the presence of adequate oxygen. This metabolic reprogramming supports rapid cancer cell proliferation and survival. However, the molecular regulators orchestrating this metabolic switch in LIHC remain incompletely understood.

The recent investigation sheds light on the role of RNA modifications in cancer metabolism, specifically focusing on 5-methylcytosine (m5C) modification, a chemical alteration of RNA that influences its stability and function. NSUN5, a member of the RNA m5C methyltransferase family, emerged as a key player. By analyzing expression data from The Cancer Genome Atlas (TCGA), the researchers discovered that both NSUN5 and EFNA3 are upregulated in LIHC and correlate strongly with poor patient survival, suggesting their contribution to tumor aggressiveness.

Mechanistically, NSUN5 was found to catalyze m5C methylation on the EFNA3 transcript. EFNA3, a gene encoding ephrin-A3, is implicated in various cellular processes including cell proliferation and migration, often hijacked during tumorigenesis. The m5C modification by NSUN5 stabilizes EFNA3 mRNA, enhancing its expression and facilitating enhanced glycolytic activity in tumor cells. This epigenetic modification essentially fuels the metabolic machinery that cancer cells rely on for growth and survival.

The research team employed a combination of in vitro and in vivo models to validate their findings. Knocking down NSUN5 in liver cancer cell lines resulted in a significant decrease in both cell viability and glycolytic activity, highlighting the enzyme’s critical role in maintaining the metabolic phenotype necessary for tumor progression. Interestingly, the suppression of NSUN5 also translated to slower tumor growth in animal xenograft models, reinforcing its tumourigenic importance.

Further molecular assays revealed a positive correlation between NSUN5 and EFNA3 expression. Notably, the overexpression of EFNA3 was able to rescue the inhibitory effects on glycolysis and cell viability caused by NSUN5 knockdown, underscoring that EFNA3 acts downstream of NSUN5’s epigenetic regulation. This finding confirms the NSUN5-m5C-EFNA3 axis as a critical pathway promoting LIHC progression.

Epitranscriptomics—the study of chemical modifications on RNA—has rapidly emerged as a frontier in understanding cancer biology. This study contributes significantly to that field by elucidating how m5C modification dynamically regulates gene expression relevant to tumor metabolism. Unlike genetic mutations, such epigenetic modifications offer a reversible means of regulating oncogenes and tumor suppressors, opening avenues for targeted therapy.

Importantly, the implication of NSUN5 in promoting glycolysis via m5C methylation of EFNA3 introduces a dual avenue for therapeutic exploitation. Targeting NSUN5 could disrupt the metabolic advantage tumor cells maintain, while simultaneously destabilizing oncogenic mRNA transcripts. Such strategies could potentially enhance the efficacy of existing treatments or lead to innovative drug designs aimed at the epitranscriptomic machinery.

Given that LIHC remains a leading cause of cancer-related mortality worldwide, largely due to limited therapeutic options, these findings inject fresh hope into the research and clinical communities. New therapeutic targets are urgently needed, especially those capable of halting cancer metabolism which fuels tumor growth and therapy resistance.

Furthermore, the findings of this study emphasize the importance of integrating RNA modification profiling in cancer diagnostics and treatment planning. Measuring NSUN5 and EFNA3 levels, alongside known biomarkers, could improve prognostic accuracy and help tailor personalized medical interventions for LIHC patients.

The study also raises intriguing questions about the broader roles of m5C modifications in other cancers and metabolic disorders. Whether NSUN5 influences other metabolic pathways or interacts with additional epigenetic regulators remain exciting topics for future research. Decoding the full spectrum of NSUN5’s targets could illuminate new principles of tumor biology.

While much work remains before these insights translate into clinical therapies, the study lays a robust foundation for drug development, including small molecule inhibitors or RNA-based therapeutics targeting the NSUN5-EFNA3 axis. Such agents could effectively ‘starve’ tumors of their glycolytic fuel source, crippling their growth capabilities.

Ultimately, this work exemplifies the power of multi-disciplinary research combining bioinformatics, molecular biology, and translational animal studies. As researchers continue to unpack the complex epigenetic networks in cancer, targeting RNA modification enzymes like NSUN5 holds considerable promise for more effective and less toxic cancer treatments.

In conclusion, the current study offers compelling evidence that NSUN5 serves as a key epitranscriptomic regulator in LIHC, accelerating tumor progression through m5C-mediated stabilization of EFNA3 and subsequent enhancement of glycolysis. These insights underscore the potential of NSUN5 as a valuable biomarker and a novel, actionable target to combat one of the most lethal cancers globally.


Subject of Research: Mechanisms by which the RNA methyltransferase NSUN5 influences glycolysis and tumor progression in liver hepatocellular carcinoma via m5C modification of EFNA3.

Article Title: NSUN5 accelerates the progression of liver hepatocellular carcinoma by m5C-EFNA3-mediated glycolysis

Article References: Han, Y., Deng, X., Chen, H., Chen, J., Xu, W., & Liu, L. (2025). NSUN5 accelerates the progression of liver hepatocellular carcinoma by m5C-EFNA3-mediated glycolysis. BMC Cancer, 25(1), Article 1237. https://doi.org/10.1186/s12885-025-14714-8

Image Credits: Scienmag.com

DOI: 10.1186/s12885-025-14714-8

Keywords: aerobic glycolysis Warburg effect, aggressive liver cancer prognosis, cancer metabolism regulation, liver hepatocellular carcinoma research, m5C EFNA3 glycolysis, metabolic reprogramming in tumors, novel cancer treatment strategies, NSUN5 liver cancer mechanism, RNA methyltransferase role in cancer, RNA modifications in cancer, therapeutic targets for LIHC, tumor growth promotion mechanisms

Cite Scienmag News

Nathaniel Bowman. (August 3, 2025). NSUN5 Drives Liver Cancer via m5C-EFNA3 Glycolysis. Scienmag. https://scienmag.com/nsun5-drives-liver-cancer-via-m5c-efna3-glycolysis/

Nathaniel Bowman. "NSUN5 Drives Liver Cancer via m5C-EFNA3 Glycolysis." Scienmag, 3 August 2025, https://scienmag.com/nsun5-drives-liver-cancer-via-m5c-efna3-glycolysis/. Accessed 12 November 2026.

Nathaniel Bowman. "NSUN5 Drives Liver Cancer via m5C-EFNA3 Glycolysis." Scienmag. August 3, 2025. https://scienmag.com/nsun5-drives-liver-cancer-via-m5c-efna3-glycolysis/

Tags: aerobic glycolysis Warburg effectaggressive liver cancer prognosiscancer metabolism regulationliver hepatocellular carcinoma researchm5C EFNA3 glycolysismetabolic reprogramming in tumorsnovel cancer treatment strategiesNSUN5 liver cancer mechanismRNA methyltransferase role in cancerRNA modifications in cancertherapeutic targets for LIHCtumor growth promotion mechanisms
Share26Tweet17
Previous Post

Noradrenaline Boosts Amygdala Memory Precision for Similar Events

Next Post

Coping Styles Linked to Substance Use in Psychiatry

Related Posts

Baseline Circulating Tumor Cells Linked to Cancer-Specific Survival in Laryngopharyngeal Carcinoma
Cancer

Baseline Circulating Tumor Cells Linked to Cancer-Specific Survival in Laryngopharyngeal Carcinoma

November 12, 2026
Radio-Immunomics Links Imaging to Liver Tumor Immune Features but Remains Investigational
Cancer

Radio-Immunomics Links Imaging to Liver Tumor Immune Features but Remains Investigational

November 12, 2026
Study Uncovers Care Coordination Hurdles and Gaps in Cancer Survivorship Knowledge
Cancer

Study Uncovers Care Coordination Hurdles and Gaps in Cancer Survivorship Knowledge

November 12, 2026
Multimodal Deep Learning Achieves Highest Accuracy in Gastric Cancer Diagnostic Network Meta-Analysis
Cancer

Multimodal Deep Learning Achieves Highest Accuracy in Gastric Cancer Diagnostic Network Meta-Analysis

November 12, 2026
Higher FADS3 Expression Linked to Hepatocellular Carcinoma Risk and Adverse Prognosis
Cancer

Higher FADS3 Expression Linked to Hepatocellular Carcinoma Risk and Adverse Prognosis

November 12, 2026
Breast Milk Sugar 3’SL Supports Intestinal Maturation and Bilirubin Clearance in Mice
Cancer

Breast Milk Sugar 3’SL Supports Intestinal Maturation and Bilirubin Clearance in Mice

November 12, 2026
Next Post
Coping Styles Linked to Substance Use in Psychiatry

Coping Styles Linked to Substance Use in Psychiatry

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Irreversible Charge Transfer in Copper Complexes Drives Carbon Radical Generation
  • Simulations Reveal Dynamic Impact of Vessel Collisions on Railway Bridge Safety
  • Salt-Tolerant Bacteria Offer Sustainable Path to Bioplastic Production
  • Adenosine Stress Echocardiography Identifies Hidden Cardiac Risks in Chronic Coronary Patients

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,150 other subscribers

© 2026 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2026 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading